Stock Price Quote

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE3680.4013.8 (+0.38 %)
PREV CLOSE ( ) 3666.60
OPEN PRICE ( ) 3679.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16560
TODAY'S LOW / HIGH ( )3640.65 3700.00
52 WK LOW / HIGH ( )3365.1 5425
NSE3681.0014.7 (+0.4 %)
PREV CLOSE( ) 3666.30
OPEN PRICE ( ) 3665.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3681.00 (105)
VOLUME 345510
TODAY'S LOW / HIGH( ) 3638.30 3699.95
52 WK LOW / HIGH ( )3365.55 5425.1
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-10 1990
Management Info
Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director
Registered Office

Address 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone 040 2378 6300

Email mail@divislabs.com

Website www.divislabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

23May Divi’s Laboratories reports 78% rise i
Divi’s Laboratories has reported results for fourth quarter and year end..
12May Divi's Laboratories informs about comp
Divi's Laboratories has informed that it enclosed the Annual Secretarial..
12Apr Divi's Laboratories informs about non-
With reference to the SEBI circular No. SEBI/HO/DDHS/CIR/P/2018/144 date..
26Feb Divi’s Laboratories informs about news
Divi’s Laboratories has informed that it enclosed copies of newspaper ad..
11Feb Divi's Laboratories reports 92% rise i
Divi's Laboratories has reported results for third quarter ended Decembe..

Financials

in Millions
QTR Mar 22 ANNUAL 22
Net Profit8829.629485.4
Gross Profit 10656.9 36765.2
Operating Profit 11464.839877.2
Net Sales 24950.388798.2

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  18088.00 (0.34%)
M.Cap ( in Cr)38435.74
Procter&Gamble Healt (BSE)
peergroup  4059.10 (1.14%)
M.Cap ( in Cr)6737.86
Medicamen Biotech (BSE)
peergroup  627.95 (7.66%)
M.Cap ( in Cr)767.14
SMS Lifesciences (BSE)
peergroup  693.85 (6.13%)
M.Cap ( in Cr)209.77
Gland Pharma (BSE)
peergroup  2643.70 (1.40%)
M.Cap ( in Cr)43530.09

Shareholding Pattern

PROMOTERS 51.94%
MUTUAL FUNDS/UTI 13.68%
NON-INSTITUTION 11.28%
FI/BANKS/INSURANCE 0.05%
GOVERNMENT 0%
FII 0%

About Divi's Laboratories Ltd.

Divi's Laboratories Ltd. was incorporated in the year 1990. Its today's share price is 3680.4. Its current market capitalisation stands at Rs 97703.06 Cr. In the latest quarter, company has reported Gross Sales of Rs. 68203.4 Cr and Total Income of Rs.68620.6 Cr. The company's management includes Nilima Prasad Divi, M Satish Choudhury, K V Chowdary, Sunaina Singh, S Ganapaty, KVK Seshavataram, R Ranga Rao, G Suresh Kumar, Ramesh BV Nimmagadda, Madhusudana Rao Divi, Kiran S Divi, N V Ramana, Murali K Divi.

It is listed on the BSE with a BSE Code of 532488 , NSE with an NSE Symbol of DIVISLAB and ISIN of INE361B01024. It's Registered office is at 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,GachibowliHyderabad-500032, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Price Waterhouse Chartered Accountants LLP, PVRK Nageswara Rao & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)